Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.

David O Kennedy
David O Kennedy
Northumbria University
United Kingdom
Crystal F Haskell
Crystal F Haskell
Northumbria University
United Kingdom
Andrew B Scholey
Andrew B Scholey
Northumbria University
United Kingdom

Hum Psychopharmacol 2007 Dec;22(8):559-66

Human Cognitive Neuroscience Unit, Division of Psychology, Northumbria University, Newcastle upon Tyne, UK.

Previous research from our laboratory demonstrated that administration of single doses (120, 240, 360 mg) of standardised Ginkgo biloba extract (GBE) had linear, dose-dependent, positive effects on the speed of performing attention tasks in comparison to placebo. However, whilst the lowest dose, which is typical of a recommended daily dose, had no effect on the speed of attention task performance it did engender mild improvements in secondary memory performance. The current study presents a reanalysis of data from three methodologically identical studies that each included a treatment of 120 mg GBE and matched placebo. All three studies were of a multiple dose, placebo-controlled, double-blind, balanced-crossover design, employing four or five treatment arms in total. Across the studies 78 healthy young participants received 120 mg GBE and placebo in randomly counterbalanced order, separated by a wash-out period of at least 7 days. On each study day participants' performance on the Cognitive Drug Research (CDR) computerised cognitive assessment battery was measured immediately prior to dosing and at 1, 2.5, 4 and 6 hr following treatment, with scores collapsed into the six measures (speed of attention, accuracy of attention, secondary memory, working memory, speed of memory, quality of memory) which have previously been derived by factor analysis of the data from CDR subtests. The results showed that 120 mg of Ginkgo engendered a significant improvement on the 'quality of memory' factor that was most evident at 1 and 4 hr post-dose, but had a negative effect on performance on the 'speed of attention' factor that was most evident at 1 and 6 hr post-dose. The current study confirmed the previous observation of modestly improved memory performance following 120 mg of GBE, but suggests that acute administration of this typical daily dose may have a detrimental effect on the speed of attention task performance which is opposite to that seen previously following higher doses.

Download full-text PDF

Source Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
December 2007
60 Reads

Publication Analysis

Top Keywords

120 gbe
speed attention
ginkgo biloba
attention task
120 ginkgo
daily dose
factor evident
evident post-dose
task performance
biloba extract
doses 120
memory performance
current study
healthy young
secondary memory
single doses


(Supplied by CrossRef)
Article in Cell Mol Life Sci
Ahlemeyer et al.
Cell Mol Life Sci 2003
Article in J Neurochem
Ahmad et al.
J Neurochem 2005
Article in Biochem Mol Biol Int
Akiba et al.
Biochem Mol Biol Int 1998
Article in Cochrane Database Syst Rev
Birks et al.
Cochrane Database Syst Rev 2002
Article in Hum Psychopharmacol Clin Exp
Canter et al.
Hum Psychopharmacol Clin Exp 2007
Article in J Ocul Pharmacol Ther
Chung et al.
J Ocul Pharmacol Ther 1999
Article in Drug Dev Res
DeFeudis et al.
Drug Dev Res 2004
Article in Age
Droy-Lefaix et al.
Age 1997
Article in Psychopharmacology
Elsabagh et al.
Psychopharmacology 2005
Article in Presse Med
Hindmarch et al.
Presse Med 1986
Article in Biochem Pharmacol
Jannsens et al.
Biochem Pharmacol 1999

Similar Publications